Expected and Unexpected Side Effects of Nanodrugs

CLINAM · 2010, Levy L. et al.


Dr. Laurent Lévy, CEO of Nanobiotix, and Co-President of the French Technology Platform on
Nanomedicine (FTPN), Paris (F)


Nanotechnology offers revolutionary strategies to improve healthcare. Adequate nanomaterial characterization constitutes the basis to establish relevant programs of nanoparticle/biological systems cross talk evaluation. Also, the surrounding conditions significantly impact on the state of the nanoparticles in terms of their collective behavior: dispersion, aggregation, and stability in gas or liquid.

The “principle of designing” specific products is the paradigm of the nanomedecine. It is really new and it represents an essential point since creating innovative products should be supported by a previous risk evaluation based on the nanoscale chemistry. Furthermore, size does matter. Thus, both, size and chemistry of nanoparticles are probably the fundamental parameters from which all others depend on, and ultimately nanomaterial surface. And surfaces are the key players when considering safety.

By continuing to use the site, you agree to the use of cookies.En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies. More information.En savoir plus.

The cookie settings on this website are set to “allow cookies” to give you the possibility to switch between languages in a way that this will not interfere with page navigation. If you continue to use this website without changing your cookie settings or you click “Accept” below then you are consenting to this.Par défaut, les paramètres de ce site autorisent les cookies pour vous permettre notamment de naviguer entre les différentes langues disponibles. Nous utilisons des cookies pour vous proposer un site internet facile d'utilisation, sécurisé et fonctionnel. Si vous les autorisez également, cliquez sur « Accepter » ou poursuivez simplement votre navigation.